Ophthalmology Times Staff Reports

The clinical study will evaluate a noninvasive corneal strengthening procedure designed to reshape the cornea and correct refractive errors in-office without tissue removal.

A trio of retina specialists recently reviewed the clinical benefits of aflibercept 8 mg, including its extended dosing intervals, improved patient satisfaction, and enhanced treatment outcomes for various conditions.

Inaugural awards honor 3 residents in ophthalmology, optometry, and retina

The Ophthalmic World Leaders (OWL) Leadership Summit, scheduled for September 21 and 22, 2023, in Austin, Texas, will feature a lineup of prominent speakers and engaging discussions on a wide range of leadership topics and industry insights.

Nominations for the 2023 awards will close July 31, 2023.

The program is dedicated to the education of fellows and residents and offers a unique opportunity to share notable retina research with peers and mentors.